Phase I dose ‐escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - June 8, 2018 Category: Hematology Authors: Oliver G. Ottmann , Carsten M üller‐Tidow , Alwin Krämer , Richard F. Schlenk , Michael Lübbert , Gesine Bug , Utz Krug , Tilmann Bochtler , Florian Voss , Tillmann Taube , Dan Liu , Pilar Garin‐Chesa , Hartmut Döhner Source Type: research